Multiprofile Hospital For Active Treatment Ivan Skenderov EOOD
- Address
- lock Available on a paid plan
Cardiovascular Disease Clinical Research
The Clinic of Cardiology at Multiprofile Hospital For Active Treatment Ivan Skenderov EOOD focuses on innovative studies aimed at improving outcomes for patients with heart failure and related conditions.
- Evaluation of a novel therapy (JTT-861) for heart failure with reduced ejection fraction
- Combination of vicadrostat and empagliflozin to reduce cardiovascular death and hospitalisation
- Investigation of NNC0487-0111 in HFpEF and obesity
These trials aim to test new treatments, assess safety, and measure impacts on hospitalization and mortality, offering hope for better management of chronic cardiac conditions.
Acute Myocardial Infarction Studies
Research at the site includes studies targeting the early treatment of acute myocardial infarction (AMI) to lower the risk of future cardiovascular events.
- Self‑administered selatogrel for rapid symptom relief in suspected AMI
- Monthly ziltivekimab injections to reduce inflammation and major adverse cardiovascular events after AMI
- Exploration of inflammatory pathways (IL‑6) as a therapeutic target in post‑AMI patients
The primary goal is to demonstrate efficacy and safety of these approaches, potentially shaping new standards for post‑heart‑attack care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Multiprofile Hospital For Active Treatment Ivan Skenderov EOOD
lock Showing 1 of 8 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized, Placebo‑Controlled Trial of Zenagamtide (NNC0487‑0111) in Obese Patients with HFpEF or HFmrEF to Reduce CV Death and HF Hospitalization | Novo Nordisk A/S | Phase III | Recruiting | Apr 2026 | — |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bi 690517 | 2 | Unknown | 2024-10-18 | 2025-08-22 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.